Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acne Vulgaris (Phase 1)
Cardiovascular Diseases (Phase 1/Phase 2)
Child, Hospitalized (Phase 2)
Cognitive Aging (Phase 3)
Communicable Diseases (Phase 3)
Convalescence (Phase 2)
Coronavirus (Phase 3)
Coronavirus Infections (Phase 3)
COVID-19 (Phase 3)
Deficiency Diseases (Phase 3)
Diabetes Mellitus (Phase 1/Phase 2)
Drugs, Investigational (Phase 1/Phase 2)
Drug Therapy (Phase 1/Phase 2)
Egypt (Phase 3)
Healthy Volunteers (Phase 1)
Hemorrhagic Fever, Ebola (Phase 2/Phase 3)
Immunoglobulins (Phase 3)
Immunosuppression Therapy (Phase 1/Phase 2)
Kidney Diseases (Phase 1/Phase 2)
Kidney Transplantation (Phase 1/Phase 2)
Lung Diseases, Interstitial (Phase 1)
Neoplasms (Phase 2/Phase 3)
Plasma (Phase 3)
Pneumonia (Phase 2)
Pneumonia, Viral (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Respiratory Distress Syndrome (Phase 2/Phase 3)
Respiratory Insufficiency (Phase 2)
Respiratory Tract Diseases (Phase 2)
RNA Virus Infections (Phase 3)
SARS-CoV-2 (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Ventilators, Mechanical (Phase 2)
Virus Diseases (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue